abstract |
Novel compounds of the formula (I), in which D, E, G, W, X, Y, T, R 1 and R 2 have the meaning indicated in Patent Claim ( 1 ), are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumours. |